RDYDr. Reddy's Laboratories Limited
$12.46-16% 1Y
$12.46
$11.4052 weeks$15.25
What is the market doing?
Mixed
2 neutral, 1 without dataNo clear lean: rangebound and lightly shorted.
TrendRangeboundderived · Oct 9, 2026
Rangebound, no clear trend. Price is −6% vs its 200-day average.
Short interest2.9% of sharesFINRA · Sep 15, 2026
Lightly shorted, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How RDY is trading
Dr. Reddy's Laboratories Limited is −16% over the past year while the S&P 500 is +18%: 34 points behind the market.
−16%
1-year return · S&P 500 +18%
- vs 200-day average
- −6.1%
vs 200-day average · below trend, but not far
- RSI (14)
- 51
RSI (14) · neutral
- Below its 52-week high
- 18%
Below its 52-week high
Details›
- Last close2026-10-09
- $12.46
- 1 monthS&P 500 +2.7%
- +6.4%
- 1 yearS&P 500 +18%
- −16%
- 5 yearsS&P 500 +88%
- −2.9%
- vs 50-day average$12.18
- +2.3%
- 52-week high
- $15.25
- 52-week low
- $11.40
- Annualised volatility
- 27%
| Year | Return |
|---|---|
| 2026 (year to date) | −11% |
| 2025 | −11% |
| 2024 | +14% |
| 2023 | +36% |
| 2022 | −20% |
| 2021 | −7.3% |
| 2020 | +77% |
| 2019 | +8.4% |
| 2018 | +1.3% |
| 2017 | −16% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 4 of 10 | −3.5% |
| Feb | 10 | 2 of 10 | −2.2% |
| Mar | 10 | 6 of 10 | +0.84% |
| Apr | 10 | 7 of 10 | +5.0% |
| May | 10 | 4 of 10 | −2.5% |
| Jun | 10 | 8 of 10 | +6.2% |
| Jul | 11 | 3 of 11 | −4.1% |
| Aug | 11 | 6 of 11 | +0.65% |
| Sep | 11 | 7 of 11 | +3.1% |
| Oct | 11 | 4 of 11 | −1.3% |
| Nov | 10 | 7 of 10 | +2.3% |
| Dec | 10 | 4 of 10 | +1.8% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers, Specialty & Generic
Ranks #3 of 41 by RyuScore